Ge Healthcare [GEHC] vs Doximity [DOCS] Detailed Stock Comparison
Ge Healthcare
NASDAQ
Loading...
Doximity
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Ge Healthcare wins in 12 metrics, Doximity wins in 7 metrics, with 0 ties. Ge Healthcare appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Ge Healthcare | Doximity | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 15.25 | 52.84 | Ge Healthcare |
| Price-to-Book Ratio | 3.50 | 11.30 | Ge Healthcare |
| Debt-to-Equity Ratio | 107.67 | 1.16 | Doximity |
| PEG Ratio | 15.93 | 51.95 | Ge Healthcare |
| EV/EBITDA | 11.04 | 44.08 | Ge Healthcare |
| Profit Margin (TTM) | 11.22% | 39.88% | Doximity |
| Operating Margin (TTM) | 14.62% | 37.48% | Doximity |
| EBITDA Margin (TTM) | 14.62% | 37.48% | Doximity |
| Return on Equity | 25.80% | 24.25% | Ge Healthcare |
| Return on Assets (TTM) | 5.77% | 13.13% | Doximity |
| Free Cash Flow (TTM) | $1.55B | $266.74M | Ge Healthcare |
| Dividend Yield | 0.24% | N/A | N/A |
| 1-Year Return | -13.44% | 82.18% | Doximity |
| Price-to-Sales Ratio (TTM) | 1.70 | 19.64 | Ge Healthcare |
| Enterprise Value | $40.55B | $10.75B | Ge Healthcare |
| EV/Revenue Ratio | 2.03 | 18.23 | Ge Healthcare |
| Gross Profit Margin (TTM) | 39.65% | 89.18% | Doximity |
| Revenue per Share (TTM) | $44 | $3 | Ge Healthcare |
| Earnings per Share (Diluted) | $4.88 | $1.17 | Ge Healthcare |
| Beta (Stock Volatility) | 1.28 | 1.36 | Ge Healthcare |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Ge Healthcare vs Doximity Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Ge Healthcare | -0.35% | 1.94% | -1.33% | 0.67% | -20.79% | -6.35% |
| Doximity | 2.50% | -2.18% | 4.96% | 11.43% | -16.42% | 21.60% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Ge Healthcare | -13.44% | 29.36% | 29.36% | 29.36% | 29.36% | 29.36% |
| Doximity | 82.18% | 97.30% | 16.35% | 16.35% | 16.35% | 16.35% |
Performance & Financial Health Analysis: Ge Healthcare vs Doximity
| Metric | GEHC | DOCS |
|---|---|---|
| Market Information | ||
| Market Cap | $33.97B | $11.58B |
| Market Cap Category | Large cap | Large cap |
| 10 Day Avg. Volume | 5,034,167 | 2,390,453 |
| 90 Day Avg. Volume | 3,925,566 | 1,815,488 |
| Last Close | $73.40 | $65.13 |
| 52 Week Range | $57.65 - $94.80 | $34.34 - $85.21 |
| % from 52W High | -22.57% | -23.57% |
| All-Time High | $94.80 (Feb 10, 2025) | $107.79 (Sep 06, 2021) |
| % from All-Time High | -22.57% | -39.58% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.04% | 0.15% |
| Quarterly Earnings Growth | 0.14% | 0.29% |
| Financial Health | ||
| Profit Margin (TTM) | 0.11% | 0.40% |
| Operating Margin (TTM) | 0.15% | 0.37% |
| Return on Equity (TTM) | 0.26% | 0.24% |
| Debt to Equity (MRQ) | 107.67 | 1.16 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $21.27 | $5.47 |
| Cash per Share (MRQ) | $8.19 | $4.49 |
| Operating Cash Flow (TTM) | $2.00B | $294.12M |
| Levered Free Cash Flow (TTM) | $1.58B | $231.29M |
| Dividends | ||
| Last 12-Month Dividend Yield | 0.24% | N/A |
| Last 12-Month Dividend | $0.18 | N/A |
Valuation & Enterprise Metrics Analysis: Ge Healthcare vs Doximity
| Metric | GEHC | DOCS |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 15.25 | 52.84 |
| Forward P/E | 15.93 | 51.95 |
| PEG Ratio | 15.93 | 51.95 |
| Price to Sales (TTM) | 1.70 | 19.64 |
| Price to Book (MRQ) | 3.50 | 11.30 |
| Market Capitalization | ||
| Market Capitalization | $33.97B | $11.58B |
| Enterprise Value | $40.55B | $10.75B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 2.03 | 18.23 |
| Enterprise to EBITDA | 11.04 | 44.08 |
| Risk & Other Metrics | ||
| Beta | 1.28 | 1.36 |
| Book Value per Share (MRQ) | $21.27 | $5.47 |
Financial Statements Comparison: Ge Healthcare vs Doximity
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | GEHC | DOCS |
|---|---|---|
| Revenue/Sales | $4.78B | $145.91M |
| Cost of Goods Sold | $2.77B | $15.79M |
| Gross Profit | $2.01B | $130.12M |
| Research & Development | $344.00M | $26.80M |
| Operating Income (EBIT) | $628.00M | $54.52M |
| EBITDA | $842.00M | $57.31M |
| Pre-Tax Income | $692.00M | $64.15M |
| Income Tax | $104.00M | $10.83M |
| Net Income (Profit) | $588.00M | $53.32M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | GEHC | DOCS |
|---|---|---|
| Cash & Equivalents | $2.45B | $209.61M |
| Total Current Assets | $9.74B | $1.09B |
| Total Current Liabilities | $9.97B | $156.26M |
| Long-Term Debt | $7.06B | $10.19M |
| Total Shareholders Equity | $9.42B | $1.08B |
| Retained Earnings | $3.81B | $186.89M |
| Property, Plant & Equipment | $369.00M | $8.89M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | GEHC | DOCS |
|---|---|---|
| Operating Cash Flow | $509.00M | $119.90M |
| Capital Expenditures | $-152.00M | $0 |
| Free Cash Flow | $98.00M | $96.98M |
| Debt Repayment | $-257.00M | N/A |
| Common Stock Repurchase | N/A | $-26.79M |
Short Interest & Institutional Ownership Analysis
| Metric | GEHC | DOCS |
|---|---|---|
| Shares Short | 9.02M | 4.07M |
| Short Ratio | 2.31 | 2.65 |
| Short % of Float | 0.03% | 0.03% |
| Average Daily Volume (10 Day) | 5,034,167 | 2,390,453 |
| Average Daily Volume (90 Day) | 3,925,566 | 1,815,488 |
| Shares Outstanding | 456.96M | 188.88M |
| Float Shares | 455.36M | 133.18M |
| % Held by Insiders | 0.00% | 0.02% |
| % Held by Institutions | 0.81% | 0.96% |
Dividend Analysis & Yield Comparison: Ge Healthcare vs Doximity
| Metric | GEHC | DOCS |
|---|---|---|
| Last 12-Month Dividend | $0.18 | N/A |
| Last 12-Month Dividend Yield | 0.24% | N/A |
| 3-Year Avg Annual Dividend | $0.11 | N/A |
| 3-Year Avg Dividend Yield | 0.04% | N/A |
| 3-Year Total Dividends | $0.33 | N/A |
| Ex-Dividend Date | Jul 25, 2025 | N/A |